Viking Therapeutics has multiple promising drugs in its portfolio that could generate billions in future revenue. Approval of VK2735 and VK2809 could lead to a surge in the stock's value.

Claim your 7-day free trial now. Vera Therapeutics, Inc. VERA said on Wednesday that it had completed full enrollment (431 participants) in the pivotal ORIGIN Phase 3 trial of atacicept in ...

Contineum Therapeutics (Nasdaq: CTNM), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I ...

We've identified the following companies as similar to CARsgen Therapeutics Holdings Ltd because they operate in a related industry or sector. We also considered size, growth, and various financial ...

And in November 2024, our license partner, Cutia Therapeutics, received regulatory approval to market AmZEEK in China, which triggered a $1 million milestone payment to Journey. Continuing the ...

RNA therapeutics have existed since the late 90s but have only come into focus in the last few years. This renewed interest has largely been attributed to the success of messenger RNA (mRNA) vaccines ...

Lyndra Therapeutics, which spun out of Moderna co-founder Robert Langer’s lab at the Massachusetts Institute of Technology in 2015, is winding down operations this week, a person with knowledge ...

Eric Westin, M.D., promoted to chief medical officer and Jim MacDonald-Clink promoted to senior vice president, head of business development CAMBRIDGE, England & BOSTON, March 27, 2025--(BUSINESS ...

2024 reflects a $1.0 million milestone payment pursuant to Journey’s license agreement with Cutia Therapeutics (HK) Limited (“Cutia”) that became payable to us upon Cutia receiving marketing approval ...

The Massachusetts-based Lyndra Therapeutics Inc “is ceasing operations from March 26th, due to insufficient funding to continue their business activities,” said Sun Pharmaceutical Industries ...